Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, June 14 '25)

Image
By G.M.

 


    Antiviral Res

  1. MARTINEZ-GZEGOZEWSKA Y, Rasmussen L, Nebane NM, McKellip S, et al
    High-throughput screening for identification of Influenza A inhibitors using a cell-based immunofluorescence assay.
    Antiviral Res. 2025 Jun 6:106209. doi: 10.1016/j.antiviral.2025.106209.
    PubMed         Abstract available


    Arch Virol

  2. LU Y, Ni J, Huang S, Guo Y, et al
    Epidemiological characteristics of human parainfluenza virus infections and phylogenetic analysis of human parainfluenza virus type 3 isolated from children with respiratory tract infections from 2020 to 2022 in Zhejiang, China.
    Arch Virol. 2025;170:157.
    PubMed         Abstract available

  3. JIN H, Cho YR, Jung YT
    Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry.
    Arch Virol. 2025;170:149.
    PubMed         Abstract available


    Cell

  4. STEVENS J, Culberson E, Kinder J, Ramiriqui A, et al
    Microbiota-derived inosine programs protective CD8(+) T cell responses against influenza in newborns.
    Cell. 2025 Jun 3:S0092-8674(25)00563-X. doi: 10.1016/j.cell.2025.
    PubMed         Abstract available


    Drug Saf

  5. ROQUE-PEREIRA L, Sisay MM, Ogar CK, Duran CE, et al
    Comparison of Adverse Events in Pregnant Persons Receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis Using Combined Data from US VAERS and EudraVigilance Spontaneous Report Databases.
    Drug Saf. 2025 Jun 10. doi: 10.1007/s40264-025-01561.
    PubMed         Abstract available


    Epidemiol Infect

  6. BARBER CA, Chien LC, Labus B, Crank K, et al
    Application of joinpoint regression to SARS-CoV-2 wastewater-based epidemiology in Las Vegas, Nevada, USA.
    Epidemiol Infect. 2025;153:e68.
    PubMed         Abstract available


    Eur J Epidemiol

  7. LI Y, Li H, Adair T
    The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis.
    Eur J Epidemiol. 2025;40:463-474.
    PubMed         Abstract available


    J Virol

  8. JONES JE, Lakdawala SS
    Host origin is a determinant of coevolution between gene segments of avian H9 influenza viruses.
    J Virol. 2025 Jun 13:e0151824. doi: 10.1128/jvi.01518.
    PubMed         Abstract available

  9. LV H, Teo QW, Lee C-CD, Liang W, et al
    Correction for Lv et al., "Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model".
    J Virol. 2025 Jun 12:e0078325. doi: 10.1128/jvi.00783.
    PubMed        

  10. SULLIVAN OM, Nesbitt DJ, Schaack GA, Feltman EM, et al
    IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.
    J Virol. 2025 Jun 11:e0028625. doi: 10.1128/jvi.00286.
    PubMed         Abstract available


    J Virol Methods

  11. COLOTTE M, Luis A, Coudy D, Tuffet S, et al
    Room temperature storage and shipping of encapsulated synthetic RNAs as quality control materials for SARS-CoV-2 molecular diagnostic assays.
    J Virol Methods. 2025;337:115169.
    PubMed         Abstract available

  12. CHENTOUFI HA, Galipeau Y, Arnold C, Dewar-Darch D, et al
    Comparative performance of serum and plasma samples in SARS-CoV-2 serology and neutralization assays.
    J Virol Methods. 2025;337:115186.
    PubMed         Abstract available


    PLoS One

  13. DAS B, Heath LS
    Variant evolution graph: Can we infer how SARS-CoV-2 variants are evolving?
    PLoS One. 2025;20:e0323970.
    PubMed         Abstract available

  14. BURHAN E, Azzumar F, Sinuraya FAG, Prasetyo S, et al
    Vaccine effectiveness of inactivated and mRNA COVID-19 vaccine platform during Delta and Omicron wave in Jakarta, Indonesia: A test-negative case-control study.
    PLoS One. 2025;20:e0320779.
    PubMed         Abstract available

  15. LOGANATHAN T, Zaini AZ, Majid HA
    Exploring the barriers and facilities migrants face in accessing COVID-19 vaccines in Malaysia: A qualitative study.
    PLoS One. 2025;20:e0326045.
    PubMed         Abstract available

  16. KUATEWO M, Ebelin W, Doegah PT, Aberese-Ako M, et al
    Fake news, misinformation, vaccine hesitancy and the role of community engagement in COVID-19 vaccine acceptance in Southern Ghana.
    PLoS One. 2025;20:e0316969.
    PubMed         Abstract available

  17. ATAC O, Peterson LE, Waters TM
    The impact of the COVID-19 pandemic on vaccinations in United States primary care practices.
    PLoS One. 2025;20:e0325934.
    PubMed         Abstract available

  18. ANAND A, Shoele K
    Identifying the effectiveness of face mask in a large population with a network-based fluid model.
    PLoS One. 2025;20:e0324229.
    PubMed         Abstract available

  19. ALJOHANI A
    A novel spectral transformation technique based on special functions for improved chest X-ray image classification.
    PLoS One. 2025;20:e0325058.
    PubMed         Abstract available

  20. WEIGL N, Pleimelding C, Gilberg L, Huynh D, et al
    Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection.
    PLoS One. 2025;20:e0325923.
    PubMed         Abstract available

  21. TANG L, Tang C, Luo H
    How regulatory orders and public fear affect vehicle mobility under COVID-19: A global perspective from urban overall vehicles using multi-source data.
    PLoS One. 2025;20:e0325118.
    PubMed         Abstract available

  22. CONNOLLY SP, Garcia Leon A, Green S, McGee D, et al
    Longitudinal SARS-CoV-2 antibody response in a healthcare worker cohort utilising the Abbott Alinity(R) anti-nucleocapsid assay.
    PLoS One. 2025;20:e0325544.
    PubMed         Abstract available

  23. CAHN P, Barreto L, Figueroa MI, Fink V, et al
    Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH).
    PLoS One. 2025;20:e0312893.
    PubMed         Abstract available

  24. PERROY B, Velasco PF, Gurchani U, Casati R, et al
    Three forms of temporal disorientation: A thematic analysis of subjective reports about Covid-19 restriction periods.
    PLoS One. 2025;20:e0324476.
    PubMed         Abstract available

  25. GERBECKS J, Yzermans CJ, Duckers MLA, Bosmans M, et al
    Health symptoms and post-COVID-19: Comparing symptomatic groups based on self-reported and primary care data.
    PLoS One. 2025;20:e0323960.
    PubMed         Abstract available

  26. LAM CN, Kumar N, Herzig SE, Unger JB, et al
    Associations between COVID-19 infection, symptom severity, perceived susceptibility, and long-term adherence to protective behaviors: The Los Angeles pandemic surveillance cohort study.
    PLoS One. 2025;20:e0326097.
    PubMed         Abstract available

  27. KHAMMAWAN P, Thongprachum A, Intawong K, Chariyalertsak S, et al
    Severity, mortality, long COVID-19, and quality of life: Insights from a cohort study of hospitalized COVID-19 patients during the delta variant predominance period in Thailand.
    PLoS One. 2025;20:e0324061.
    PubMed         Abstract available

  28. HASHMI E, Altaf A, Anwar MW, Jamal MH, et al
    BI-SENT: bilingual aspect-based sentiment analysis of COVID-19 Tweets in Urdu language.
    PLoS One. 2025;20:e0317562.
    PubMed         Abstract available

  29. LAIL AJ, Vuyk WC, Machkovech H, Minor NR, et al
    Amplicon sequencing of pasteurized retail dairy enables genomic surveillance of H5N1 avian influenza virus in United States cattle.
    PLoS One. 2025;20:e0325203.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  30. HUOT M, Wang D, Liu J, Shakhnovich EI, et al
    Predicting high-fitness viral protein variants with Bayesian active learning and biophysics.
    Proc Natl Acad Sci U S A. 2025;122:e2503742122.
    PubMed         Abstract available

  31. GOZZI N, Perra N, Vespignani A
    Comparative evaluation of behavioral epidemic models using COVID-19 data.
    Proc Natl Acad Sci U S A. 2025;122:e2421993122.
    PubMed         Abstract available

  32. CAOBI A, Su CM, Beusch CM, Kenney D, et al
    SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses.
    Proc Natl Acad Sci U S A. 2025;122:e2426528122.
    PubMed         Abstract available


    Virus Res

  33. ZHOU X, Feng L
    The Association Between Influenza Infection and Acute Myocardial Infarction: A Comprehensive Systematic Review and Meta-Analysis.
    Virus Res. 2025 Jun 9:199594. doi: 10.1016/j.virusres.2025.199594.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »